InsidersTradesSigma
Follow the WAVE LIFE SCIENCES INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €965.5m. The latest transaction was filed on 12 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: ADRIAN G RAWCLIFFE. The full history is free.
Analysts rate WAVE LIFE SCIENCES INC Strong Buy (bullish), based on 16 analysts. Average price target: US$19.06.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
WAVE Life Sciences Inc is a biopharmaceutical company focused on developing therapies for genetic diseases. It utilizes an RNA design platform to create targeted treatments.